Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Cells · 19.09.2024 · 13 (18) · 1574
DOI: 10.3390/cells13181574 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 19.09.2024. Verfasst von Ashley Irin Cortes Ballen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunterian Neurosurgical Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khatib Brain Tumor Center.
Abstract (Originalsprache)
Glioblastoma (GBM) is an aggressive and highly malignant primary brain tumor characterized by rapid growth and a poor prognosis for patients. Despite advancements in treatment, the median survival time for GBM patients remains low. One of the crucial challenges in understanding and treating GBMs involves its remarkable cellular heterogeneity and adaptability. Central to the survival and proliferation of GBM cells is their ability to undergo metabolic reprogramming. Metabolic reprogramming is a process that allows cancer cells to alter their metabolism to meet the increased demands of rapid growth and to survive in the often oxygen- and nutrient-deficient tumor microenvironment. These changes in metabolism include the Warburg effect, alterations in several key metabolic pathways including glutamine metabolism, fatty acid synthesis, and the tricarboxylic acid (TCA) cycle, increased uptake and utilization of glutamine, and more. Despite the complexity and adaptability of GBM metabolism, a deeper understanding of its metabolic reprogramming offers hope for developing more effective therapeutic interventions against GBMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunterian Neurosurgical Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
ORCID-Profile: Emre Derin, Hasan Slika, Betty Tyler
Förderung
- Khatib Brain Tumor Center
Zitieren
APA
Cortes Ballen, A. I., Amosu, M., Ravinder, S., Chan, J., Derin, E., Slika, H., & Tyler, B. (2024). Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets. Cells, 13(18), 1574. https://doi.org/10.3390/cells13181574
Vancouver
Cortes Ballen AI, Amosu M, Ravinder S, Chan J, Derin E, Slika H, et al. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets. Cells. 2024;13(18):1574. doi:10.3390/cells13181574
BibTeX
@article{CortesBallen2024,
author = {Cortes Ballen, Ashley Irin and Amosu, Maryam and Ravinder, Surya and Chan, Joey and Derin, Emre and Slika, Hasan and Tyler, Betty},
title = {Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets},
journal = {Cells},
year = {2024},
volume = {13},
number = {18},
pages = {1574},
doi = {10.3390/cells13181574}
}
EUVIMED